ACCC, along with 195 patient advocacy, public health, and provider organizations, issued a statement supporting the introduction of S. 4440, the Clinical Trial Modernization Act, in the Senate. This important legislation will increase access to clinical trials for underrepresented communities such as those in rural areas and/or those who are low income, reduce bureaucratic red tape, and enhance U.S. innovation and leadership in developing new treatments and therapies. Read the full letter.
January 21, 2026
October 30, 2025
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
